Invitation Only Virtual Investor Conference To
Be Held October 21, 2020
Speakers Include Regulatory Experts Dr. Daniel
Fabricant
Sponsored by Jefferies, Oppenheimer & Co.
and ThinkEquity
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”),
one of the leading, most highly trusted, and most recognized
cannabidiol (CBD) brands, announced today that in conjunction with
the Natural Products Association (NPA), with the goal to better
clarify the landscape for investors, is launching an invitation
only virtual investor conference entitled “Regulatory Roadmap For
The CBD Industry”, which will focus on discussing the current
regulatory climate in the CBD industry.
The conference will be moderated by Lance Blundell, Esq. Counsel
for cbdMD, alongside Owen Bennett from Jefferies, Rupesh Parikh
from Oppenheimer & Co. and Ashok Kumar from ThinkEquity.
Moderators will have an opportunity to participate in a Q&A
with Dr. Daniel Fabricant, CEO of the NPA. Participants will be
invitation only at the request of the sponsors.
“The CBD industry is at an important stage in its development.
Understanding the future regulatory climate is critical for CBD
executives and their investors. Dr. Fabricant has a unique
perspective on the future regulatory landscape and cbdMD is pleased
to partner with the NPA to educate consumers, investors and
distributors in this unique format,” said Mr. Blundell.
The NPA has been the leader in asking the FDA to regulate CBD
since 2017, has testified on a number of occasions and has held
several meetings with top FDA officials on the issue. NPA also
helped craft legislation passed by the US House of Representatives
that provides resources so that the FDA can perform a Health Hazard
Evaluation (HHE) and set a safe level of CBD for consumers to use
each day. The process would follow the same precedent as red yeast
rice, which allows a natural product to contain a level of a drug
ingredient that the FDA has determined to be safe.
The conference will start on Wednesday, October 21, 2020, at
10:00 am. Invitation only requests can be made through: Jefferies,
Oppenheimer & Co. and ThinkEquity. A transcript of the
conference will be made available to the public on October 26,
2020.
About the National Products Association (NPA)
Natural Products
Association
The Natural Products Association (NPA) is the trade
association representing the entire natural products industry. We
advocate for our members who supply, manufacture and sell natural
ingredients or products for consumers. The Natural Products
Association promotes good manufacturing practices as part of the
growth and success of the industry. Founded in 1936, NPA represents
over 700 members accounting for more than 10,000 locations of
retailers, manufacturers, wholesalers and distributors of natural
products, including foods, dietary supplements, and health/beauty
aids. Visit www.npanational.org.
Daniel Fabricant, Ph.D. is CEO and President of the Natural
Products Association (NPA), the nation’s largest and oldest trade
organization representing the natural products industry, including
dietary supplements, foods, personal care products and more. Most
recently, Dr. Fabricant served as the Director of the Division of
Dietary Supplement Programs at the U.S. Food and Drug
Administration (FDA), where he directed agency policy, public
affairs and regulatory action regarding regulation of the dietary
supplement industry for more than three years. While with the
agency, he successfully navigated the large, heavily-matrixed
government organizational structure to bring life to a regulatory
function that was non-existent for almost 20 years. Dr. Fabricant
carried his interest in natural products into the classroom,
earning a Ph.D. in Pharmacognosy from the University of Illinois at
Chicago, where he has served as an adjunct professor in the
Department of Medicinal Chemistry and Pharmacognosy since 2009. He
has also published extensively and is internationally recognized
for his regulatory and governmental public health expertise and
natural products research.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading, most highly trusted, and most
recognized cannabidiol (CBD) brands, whose current products include
CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath
bombs and CBD pet products. cbdMD is also a proud partner of
Bellator MMA and Life Time, Inc., and has one of the largest
rosters of professional sports athletes who are part of “Team
cbdMD.” To learn more about cbdMD and our comprehensive line of
over 100 SKUs of U.S. produced, Non-THC1 CBD products, please visit
www.cbdMD.com, follow cbdMD on Instagram and Facebook, or visit one
of the 6,000 retail outlets that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ''should,'' ''may,''
''intends,'' ''anticipates,'' ''believes,'' ''estimates,''
''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and
''proposes.'' These forward-looking statements are not guarantees
of future performance and are subject to risks, uncertainties, and
other factors, some of which are beyond our control and difficult
to predict and could cause actual results to differ materially from
those expressed or forecasted in the forward-looking statements.
You are urged to carefully review and consider any cautionary
statements and other disclosures, including the statements made
under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on
Form 10-K for the fiscal year ended September 30, 2019 and Part II,
Item 1A. Risk Factors appearing in its Quarterly Report on Form
10-Q for the period ended June 30, 2020, both as filed with the
Securities and Exchange Commission (the "SEC") and our other
filings with the SEC. All forward-looking statements involve
significant risks and uncertainties that could cause actual results
to differ materially from those in the forward-looking statements,
many of which are generally outside the control of cbdMD, Inc. and
are difficult to predict. cbdMD, Inc. does not undertake any duty
to update any forward-looking statements except as may be required
by law. The information which appears on our websites and our
social media platforms, including, but not limited to, Instagram
and Facebook, is not part of this press release.
1 Non-THC is defined as below the level of detection using
validated scientific analytical tools.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200924005137/en/
PR: cbdMD, Inc. Lauren Greene
Communications Specialist Lauren.Greene@cbdMD.com (843)
743-9999
Investors: cbdMD, Inc. John Weston
Director of Investor Relations John.Weston@cbdMD.com (704)
249-9515
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Mar 2024 to Apr 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Apr 2023 to Apr 2024